The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 39 | 25.5x | 20.1x | Near average | |
Growth | 33 | 7.9% | 5.6% | Below average | |
Quality | 63 | 22.5% | 7.6% | Near average | |
Safety | 63 | 0.9x | 0.4x | Near average | |
Capital Return | 39 | 2.33% | 2.19% | Near average | |
Momentum | 68 | — | — | Above average | |
Sentiment | 49 | — | — | Near average |
Johnson & Johnson is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Johnson & Johnson shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
Price forecasts for Johnson & Johnson stock have shown remarkable stability in the past week, with a slight improvement in the average price target by 0.53% over the last 30 days to reach $250.58. This stability reflects a state of cautious optimism, as the stock is currently trading at a discount of approximately 11% from the average price target, indicating a potential growth gap that analysts see in the stock's fair value.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.